You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2025

List of Excipients in API DUTASTERIDE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing DUTASTERIDE

Glossary
CompanyTradenameIngredientNDCExcipientPotential Generic Entry
GlaxoSmithKline LLC AVODART dutasteride 0173-0712 BUTYLATED HYDROXYTOLUENE
GlaxoSmithKline LLC AVODART dutasteride 0173-0712 FERRIC OXIDE YELLOW
GlaxoSmithKline LLC AVODART dutasteride 0173-0712 GELATIN
GlaxoSmithKline LLC AVODART dutasteride 0173-0712 GLYCERIN
>Company>Tradename>Ingredient>NDC>Excipient>Potential Generic Entry

Subscribe to access the full database, or Try for Free

Showing 1 to 4 of 4 entries

Excipients in ANDA-approved (generic) drugs containing DUTASTERIDE

Detailed excipient profiles for DUTASTERIDE

Excipient focus: ALCOHOL

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: BUTYL ALCOHOL

Excipient focus: BUTYLATED HYDROXYTOLUENE

Excipient focus: CALCIUM STEARATE

Excipient focus: CAPRIC ACID

Excipient focus: CAPRYLIC/CAPRIC MONO/DIGLYCERIDES

Excipient focus: CARRAGEENAN

DUTASTERIDE drug variants containing CARRAGEENAN

Excipient focus: CELLULOSE, MICROCRYSTALLINE

DUTASTERIDE drug variants containing CELLULOSE, MICROCRYSTALLINE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: DIMETHICONE

Excipient focus: ETHYLCELLULOSE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL CAPRYLATE/CAPRATE

Excipient focus: GLYCERYL CAPRYLOCAPRATE

Excipient focus: GLYCERYL MONO AND DICAPRYLOCAPRATE

Excipient focus: GLYCERYL MONO- AND DICAPRYLOCAPRATE

Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE

Excipient focus: GLYCINE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

DUTASTERIDE drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

DUTASTERIDE drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Excipient focus: METHYLPARABEN

DUTASTERIDE drug variants containing METHYLPARABEN

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYVINYL ACETATE PHTHALATE

Excipient focus: POTASSIUM CHLORIDE

DUTASTERIDE drug variants containing POTASSIUM CHLORIDE

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

DUTASTERIDE drug variants containing PROPYLPARABEN

Excipient focus: SHELLAC

Excipient focus: SORBITOL

Excipient focus: SUCROSE

Excipient focus: TALC

DUTASTERIDE drug variants containing TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

DUTASTERIDE drug variants containing TRIETHYL CITRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group